HCS 490 Week 4 Health Care Regulation Implications Example

Waiting on an Answer: What the Federal Interoperability and Prior Authorization Rule Means for Health Care Consumers, Providers and Health Plans

[Student Name]

University of Phoenix

HCS/490: Health Care Consumer - Trends and Marketing

Week 4 Assignment

[Instructor Name]

[Date]

The patient example and the health plan's figures are composites written for a model paper; the rule's provisions come from the sources listed.

A 58-year-old woman with worsening back pain and numbness in her leg saw her physician in March. The physician ordered an MRI. Her Medicare Advantage plan required prior authorization, and the imaging center could not schedule the scan until approval came. The request was faxed, sent back for missing information, resubmitted and approved 13 days later. During those two weeks she missed work and called the plan four times. Her experience is the kind of problem the federal Interoperability and Prior Authorization final rule was written to address. This paper explains the rule and its implications for consumers, providers and health plans.

Why Prior Authorization Exists and Why It Frustrates

Prior authorization requires a clinician to obtain a health plan's approval before certain services, drugs or tests are covered. Plans use it to check that care is appropriate and to control costs. For consumers, it adds delay and paperwork. Kyle and Frakt (2021) found in a national survey that about a quarter of adults delayed or went without care because of administrative tasks, a category that includes prior authorization. Physicians report similar effects: in a national American Medical Association (2024) survey, nearly all physicians said prior authorization delays access to necessary care, and about a quarter reported that it had led to a serious adverse event for a patient in their care. Whatever its value in preventing unnecessary care, prior authorization as usually practiced imposes waiting, uncertainty and paperwork on the very consumers the course asks us to put at the center.

What the Rule Requires

The Centers for Medicare and Medicaid Services (2024) finalized the rule in January 2024. It applies to Medicare Advantage organizations, state Medicaid and Children's Health Insurance Program fee-for-service programs and their managed care plans, and qualified health plan issuers on the federally facilitated exchanges. Beginning in 2026, affected payers must send prior authorization decisions within 72 hours for expedited requests and within seven calendar days for standard requests, provide a specific reason when they deny a request and publicly report metrics such as approval and denial rates and average decision times. By 2027, payers must build electronic application programming interfaces that let providers check whether authorization is needed, submit requests with documentation and receive decisions, and let patients see their own prior authorization information through a patient access interface.

Implications for Consumers

For the woman waiting on her MRI, the rule would set an outer limit of seven days for a standard decision, and if the scan were denied, she and her physician would learn the specific reason, making an appeal or a corrected request easier. Consumers will also be able to see pending and completed authorizations through their plan's patient access tools, reducing calls. Public reporting will let consumers choosing a Medicare Advantage or marketplace plan compare how often plans deny requests and how quickly they decide.

Implications for Providers

Providers should spend less time on faxes and phone calls once electronic interfaces are in place, and faster decisions mean fewer rescheduled procedures. But the benefits depend on providers' own systems connecting to payers' new interfaces, which requires investment in electronic health record upgrades and staff training. In the short term, practices will run two processes at once: electronic for payers that are ready and manual for others.

Implications for Health Plans

Plans must build and maintain new interfaces, meet decision deadlines and publish data that may expose them to criticism if their denial rates are high. Some plans may respond by reducing the number of services that require prior authorization, which would benefit consumers further. Plans will also need staff and clinical reviewers able to meet the shorter deadlines during seasonal surges in requests.

How Consumers and Advocates Can Use the New Data

The public reporting requirement may matter more over time than the deadlines. Once plans post approval rates, denial rates and average decision times, consumer advocates, journalists and state regulators can compare plans. A consumer choosing among Medicare Advantage plans during open enrollment could, in principle, avoid a plan that denies a high share of requests or takes the full seven days on most decisions. For that to happen, the data must be easy to find and explained in plain language, which is a task for navigators, brokers and the plans themselves, since few consumers will read a technical report.

The Consumer's Remaining Role

Even with faster decisions, consumers will still need to know that a service requires approval, ask whether it has been submitted and understand their appeal rights if it is denied. Organizations that tell patients these things at the moment of ordering, rather than after a delay, turn the rule's protections into something consumers can actually use.

Limits of the Rule

The rule does not cover most employer-sponsored plans, which insure most working-age Americans, so many consumers will see no direct change. It does not apply to prescription drugs. It does not eliminate prior authorization or set standards for which services may require it. Deadlines of seven days still allow meaningful delays for some consumers, and full electronic processing will not arrive until 2027.

Recommendations for a Provider Organization

A health system preparing for the rule should inventory which services require prior authorization by payer, assign a revenue cycle team to track decision times against the new deadlines, plan electronic health record upgrades to connect to payer interfaces, and tell patients at the time of ordering how long approval should take and whom to call if it does not arrive.

Conclusion

The Interoperability and Prior Authorization rule addresses a real consumer burden by setting deadlines, requiring explanations, publishing data and moving requests onto electronic systems. For many consumers in public and marketplace plans, waits like the two weeks described here should shorten. For others, especially those in employer plans or waiting on prescription drugs, the burden remains, and organizations will still need to help consumers through it.

References

American Medical Association. (2024). 2023 AMA prior authorization physician survey. https://www.ama-assn.org/system/files/prior-authorization-survey.pdf

Centers for Medicare and Medicaid Services. (2024). CMS interoperability and prior authorization final rule (CMS-0057-F) [Fact sheet]. https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f

Kyle, M. A., & Frakt, A. B. (2021). Patient administrative burden in the US health care system. Health Services Research, 56(5), 755-765. https://doi.org/10.1111/1475-6773.13861